Results 241 to 250 of about 3,644,269 (284)

Lansoprazole as a possible trigger of restless legs syndrome with suspected periodic limb movement disorder in a hemodialysis patient: a case report. [PDF]

CEN Case Rep
Nakata H, Nishiwaki K.
europepmc   +1 more source

Interleukin 6 Inhibition With Vamikibart for Uveitic Macular Edema: The Phase 1 DOVETAIL Nonrandomized Clinical Trial.

JAMA Ophthalmol
Sharma S, Lin P, Hu A, Suhler EB, Pauly-Evers M, Holmes W, Barekati Z, Willen D, Macgregor L, Steeples L, Haskova Z, Feenstra D, Silverman D, Passemard B, Fauser S, Mesquida M.   +15 more
europepmc   +1 more source

Catalytic degradation of methylene blue in aqueous solution using cobalt oxide kaolin nanocomposite. [PDF]

Discov Nano
Miskir BA, Mohammed KS, Asmare ZG, Atlabachew M, Liu Y, Shiferaw T, Mehari B, Aragaw BA.   +7 more
europepmc   +1 more source

Physiologically-Based Pharmacokinetic Model-Informed Labeling for Cariprazine Drug Interactions With CYP3A Inhibitors. [PDF]

CPT Pharmacometrics Syst Pharmacol
Riad MMH, Marroum P, Shebley M, Xiong H.
europepmc   +1 more source

Modular surgical approach for angle-closure glaucoma secondary to nanophthalmos. [PDF]

Int J Ophthalmol
Gao Y, Yu XW, Deng L, Mei F, Zhang M, Zhong HY, Zhang TR, Shi Y, Fan ZG.   +8 more
europepmc   +1 more source

Absence of steatosis combined with cardiometabolic risk factors confers the highest hepatocellular carcinoma risk in treated chronic hepatitis B. [PDF]

Ann Med
Wang HW, Lai HC, Hsu WF, Chen SH, Kuo YC, Peng CY.   +5 more
europepmc   +1 more source

Clinical Manifestations of Lyme Borreliosis in Europe: Burden of Lyme Disease Study (BOLD), 2021-2022. [PDF]

Pathogens
Halsby K, Loew-Baselli A, Strle F, Moniuszko-Malinowska A, Berglund JS, Cibik V, Zakova D, Tan Y, Angulo FJ, Edwards J, Pilz A, Gessner BD, Begier E, Stark JH, On Behalf Of The Bold Study Group.   +14 more
europepmc   +1 more source